通化金马：新药已完成各项专业审评工作进入综合审评环节，审批工作正常进行中，已经处于临近审批阶段

Core Viewpoint - The company Tonghua Golden Horse (000766.SZ) confirms that its new drug approval process is progressing normally and is nearing the final approval stage [1]. Group 1: Approval Process - The company has completed all professional review work for its new drug and has entered the comprehensive review phase [1]. - The approval work is currently proceeding normally, with the new drug, Amber Dihydroaminoacridine Tablets, in the final stages of review [1]. - The company will disclose any significant information as per the relevant disclosure regulations if necessary [1].